Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
PARTNER 3: TAVR is Cost Effective Compared with SAVR for Low-Risk Patients
Author(s): David J Cohen Added: 2 years ago
Dr David J Cohen (St Francis Hospital, Roslyn, NY, US) discusses the findings from PARTNER 3 Economic Study. The study, presented first at TCT 2021, showed that for patients with severe AS and low surgical risk, TF-TAVR with the SAPIEN 3 valve is cost-saving compared with SAVR at 2-year follow-up. Discussion Points Importance of the Study Used Data Complexities in Relation to the Costs of… View more

Intervention
ACC.24: The DEDICATE Trial
Author(s): Moritz Seiffert Added: 1 week ago
ACC.24 — Investigator Dr Moritz Seiffert (University Heart and Vascular Center Hamburg, DE) joins us onsite at ACC to discuss the findings of the DEDICATE-DZHK6 Trial (NCT03112980).This randomized controlled, multi-center trial aimed to investigate whether transcatheter aortic valve implantation (TAVI) is non-inferior to surgical aortic valve replacement (SAVR) in patients with symptomatic severe… View more

Intervention
Who should be referred for TAVR
Author(s): Colin M Barker , Michael J Reardon Added: 3 years ago
Aortic stenosis (AS) has a long latent period and then rapid progression with high mortality once symptoms appear.1 The absence of an effective medical therapy for symptomatic severe AS led to a class I indication for aortic valve replacement (AVR) in both the US and European guidelines.2,3 Unfortunately, a study by Bach et al. in 2009 found that up to half of patients with symptomatic severe AS… View more

Vascular Disease and Surgery

Intervention
TAVR Versus SAVR in Young, Low-risk Patients
Author(s): Quynh Nguyen , Jessica GY Luc , Thomas E MacGillivray , et al Added: 1 year ago

Vascular Disease and Surgery

Intervention
The Evolving Role of the Heart Team in Aortic Stenosis
Author(s): Sahoor Khan , William Shi , Tsuyoshi Kaneko , et al Added: 1 year ago

Vascular Disease and Surgery

Intervention
Author(s): Michael N Young , Sammy Elmariah Added: 3 years ago
Severe aortic valve stenosis (AS) is chronic, progressive illness that confers significant morbidity and mortality. Once symptomatic, patients with severe AS will ultimately succumb to the disease if it is not promptly corrected.1 Historically, surgical aortic valve replacement (SAVR) served as the exclusive therapeutic option to correct this mechanical problem.2 However, in 2002, Alain Cribier… View more

Vascular Disease and Surgery

Intervention
Bicuspid Aortic Stenosis with and without Aortopathy: Considerations for Surgical Aortic Valve Replacement versus Transcatheter Aortic Valve Replacement
Author(s): Arthur J Lee , Imran Baig , Katherine B Harrington , et al Added: 1 year ago

Intervention
Current Strategies in the Management of Aortic Stenosis
Author(s): Anne H Tavenier , Johny Nicolas , Roxana Mehran Added: 1 year ago

Intervention
Valve-in-valve TAVR
Author(s): Emily Perdoncin , Gaetano Paone , Isida Byku Added: 2 years ago

Intervention
TCT 23: 5 Trials That Changed My Practice
Author(s): Mirvat Alasnag Added: 5 months ago
TCT 23 - We are joined by Dr Mirvat Alasnag (The King Fahd Armed Forces Hospital, SA) for an insightful summary of the late-breaking trials that are expected to have an impact on interventional science and clinical practice. Trials covered in detail include: Agent IDE ALIGN-AR PARTNER 3 EVOLUT Low-Risk TRISCEND Recorded remotely from Jeddah, 2023. Editor: Jordan Rance Video Specialist:… View more

Intervention